Tag: immunomodulatory therapies

illustration of a neuron affected by multiple sclerosis

Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

covid-19
January 13, 2023/COVID-19

Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era

As the pandemic evolves, rheumatologists must continue to be mindful of most vulnerable patients

Male patient sitting on exam table in clinic room
October 24, 2022/Digestive/Research

Study Reveals Racial Disparities in Treatment of Inflammatory Bowel Disease

Black patients less likely to receive advanced therapies

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad